FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.
For more information on lot numbers and product descriptions, see the FDA release:www.fda.gov/Safety/Recalls/ucm469980.htm



More Latest News

Telehealth
July 18, 2017

The use of telehealth technology by Florida licensed healthcare practitioners for the purpose of providing patient care within the state of Florida is not precluded by Florida law. Continue reading


2017 Legislation Impacting Your Profession
June 27, 2017

Click here to view a full list of bill summaries from the 2017 Florida Legislative Session that may impact your profession. Continue reading